Media Summary: Markus Hartmann, PhD, from European Consulting & Contracting in Oncology, Trier, Germany, discusses the This video provides a high-level overview of the regulatory Hear from Carlos Sattler, VP of Clinical Development & Medical Affairs; Julia Pike, SVP of Intellectual Property; Cindy Cao, ...

Biosimilars The Path To Approval - Detailed Analysis & Overview

Markus Hartmann, PhD, from European Consulting & Contracting in Oncology, Trier, Germany, discusses the This video provides a high-level overview of the regulatory Hear from Carlos Sattler, VP of Clinical Development & Medical Affairs; Julia Pike, SVP of Intellectual Property; Cindy Cao, ... Robin Foà, MD from the Sapienza University, Rome, Italy discusses the question of how the trials on Paul Cornes, MD, University Hospital Bristol NHS Foundation Trust, Bristol, UK, talks to us about some of the challenges we'll face ... In this presentation from the 'Here and Now:

In this episode of Biotech Stage Podcast, Arun Singhal sits down with Jake Knurek, Business Development expert at Mabion, one ...

Photo Gallery

Biosimilars: The Path to Approval
What is a Biosimilar? - Video Explainer
The Basics of Biosimilars
Dr. Kolberg Explains the Approval Process for Biosimilars
The approval process of biosimilars
Fast Facts About the Regulatory Approval Pathway for Biosimilars – Amgen Science
Biosimilars and the approval process
The Promise of Biosimilars
Quick Guide to Biosimilars
Biosimilars - the question of trials and approval
The biosimilar regulatory pathway
The Approval Process for Biosimilars
Sponsored
Sponsored
View Detailed Profile
Biosimilars: The Path to Approval

Biosimilars: The Path to Approval

Biosimilars: The Path to Approval

What is a Biosimilar? - Video Explainer

What is a Biosimilar? - Video Explainer

Do you know what a

Sponsored
The Basics of Biosimilars

The Basics of Biosimilars

What are

Dr. Kolberg Explains the Approval Process for Biosimilars

Dr. Kolberg Explains the Approval Process for Biosimilars

Abp 980 is a

The approval process of biosimilars

The approval process of biosimilars

Markus Hartmann, PhD, from European Consulting & Contracting in Oncology, Trier, Germany, discusses the

Sponsored
Fast Facts About the Regulatory Approval Pathway for Biosimilars – Amgen Science

Fast Facts About the Regulatory Approval Pathway for Biosimilars – Amgen Science

This video provides a high-level overview of the regulatory

Biosimilars and the approval process

Biosimilars and the approval process

Hear from Carlos Sattler, VP of Clinical Development & Medical Affairs; Julia Pike, SVP of Intellectual Property; Cindy Cao, ...

The Promise of Biosimilars

The Promise of Biosimilars

What are the promises that

Quick Guide to Biosimilars

Quick Guide to Biosimilars

In this Quick Guide to

Biosimilars - the question of trials and approval

Biosimilars - the question of trials and approval

Robin Foà, MD from the Sapienza University, Rome, Italy discusses the question of how the trials on

The biosimilar regulatory pathway

The biosimilar regulatory pathway

How is the use of a

The Approval Process for Biosimilars

The Approval Process for Biosimilars

Describe the

Biosimilars: Rigorous approval process

Biosimilars: Rigorous approval process

Analysis. Development. Testing.

Interchangeability of Biosimilars - Video Explainer

Interchangeability of Biosimilars - Video Explainer

In the European Union,

How Are Biosimilars Approved? | Breaking Down Biosimilars

How Are Biosimilars Approved? | Breaking Down Biosimilars

Biosimilar

Explaining biosimilars to our patients

Explaining biosimilars to our patients

Paul Cornes, MD, University Hospital Bristol NHS Foundation Trust, Bristol, UK, talks to us about some of the challenges we'll face ...

Regulatory Pathway for Biosimilars

Regulatory Pathway for Biosimilars

In this presentation from the 'Here and Now:

No More Phase 3 Trials? Biosimilars Get Faster Approval | Jake Knurek of Mabion Biologics- A Podcast

No More Phase 3 Trials? Biosimilars Get Faster Approval | Jake Knurek of Mabion Biologics- A Podcast

In this episode of Biotech Stage Podcast, Arun Singhal sits down with Jake Knurek, Business Development expert at Mabion, one ...

Freyr Regulatory Radio: Season 4 | Episode 1  Introduction and EU Approval for Biologics/Biosimilars

Freyr Regulatory Radio: Season 4 | Episode 1 Introduction and EU Approval for Biologics/Biosimilars

Introduction to

Dr. Verma Discusses the Approval Process for Biosimilars

Dr. Verma Discusses the Approval Process for Biosimilars

So